Search for a doctor

Ricardo D. Parrondo, M.D.

  1. Hematologist / Oncologist

Ricardo D. Parrondo, M.D., is a hematologist-oncologist, with a specialty interest in plasma cell dyscrasias and chronic lymphocytic leukemia. His clinical and research focus includes:

  • Expertise in management of plasma cell dyscrasias such as multiple myeloma, MGUS, monoclonal gammopathies of clinical significance, Waldenstrom macroglobulinemia, AL amyloidosis, and POEMS syndrome
  • Autologous hematopoietic cell transplantation for plasma cell dyscrasias
  • Expertise in management of relapsed/refractory plasma cell dyscrasias
  • Development of early and late-phase clinical trials for plasma cell dyscrasias
  • Expertise in management of newly diagnosed and relapsed/refractory chronic lymphocytic leukemia
  • Expertise in use of novel immunotherapeutic strategies for plasma cell dyscrasias and chronic lymphocytic leukemia such as CAR-T cell therapies and bispecific antibodies.

In addition to his clinical and research activities, Dr. Parrondo is active in education, providing mentorship to residents and fellows interested in hematologic malignancies. He publishes in high impact scientific journals and is at the helm of therapeutic discoveries for patients with plasma cell dyscrasias.

  • Multiple Myeloma
  • Waldenstrom Macroglobulinemia
  • Chronic Lymphocytic Leukemia
  • AL Amyloidosis
  • Plasma Cell Dyscrasias
  • Clinical drug development in Plasma Cell Dyscrasias
  • Biology of plasma cell disorders
  • Improving outcomes for high risk Multiple Myeloma
  1. 2021
    FellowHematology/Oncology, Programs in Florida, Mayo School of Graduate Medical Education, Mayo Clinic College of Medicine
  2. 2018
    Residency - Internal MedicineNew Jersey Medical School, Rutgers University
  3. 2015
    MD - Doctor of Medicine American University Of The Caribbean
  4. 2008
    BA - Biological Basis of Behavior and Psychology University of Pennsylvania

Certifications

  1. 2021
    Medical OncologyAmerican Board of Internal Medicine
  2. 2021
    HematologyAmerican Board of Internal Medicine
  3. 2018
    Internal MedicineAmerican Board of Internal Medicine

Awards and honors

  1. 2023
    Emerging Leaders in Bone Marrow Transplantation AwardJournal of Bone Marrow Transplantation
  2. 2023
    Mayo Clinic Experience Top Performer AwardMayo Clinic
  3. 2022
    Mayo Clinic Experience Top Performer AwardMayo Clinic
  4. 2021
    Clinical Trial Protocol Selected for Participation in ASCO/AACR Virtual Workshop on Methods in Clinical Cancer Research American Association for Cancer Research (AACR) and American Society of Clinical Oncology (ASCO)
  5. 2020
    American Scoeity of Clinical Oncology 2020 Annual Meeting Travel AwardFlorida Society of Clinical Oncology
  6. 2020
    American Society of Transplantation and Cellular Therapy 2020 Annual Meeting Travel AwardAmerican Society of Transplantation and Cellular Therapy
  7. 2019
    American Society of Hematology 2019 Annual Meeting Travel Award Florida Society of Clinical Oncology
  8. 2018
    Nominated for Golden Apple AwardRutgers University, New Jersey Medical School
  9. 2017
    Resident of the MonthRutgers University, New Jersey Medical School
  10. 2017
    Resident of the MonthRutgers University, New Jersey Medical School
  11. 2016
    Resident of the MonthRutgers University, New Jersey Medical School
  12. 2016
    Intern of the MonthRutgers University, New Jersey Medical School
  13. 2016
    Intern of the MonthRutgers University, New Jersey Medical School
  14. 2016
    Intern of the MonthRutgers University, New Jersey Medical School
  15. 2012
    Alpha Omega Phi Honor and Service Society InductionAmerican University of The Caribbean School of Medicine
  16. 2012
    Best Overall Basic Science Presentation Veterans Health Administration
  17. 2011
    Dean’s List all 5 semesters of the basic sciences American University of The Caribbean School of Medicine
  18. 2011
    Best Overall Basic Science PresentationVeterans Health Administration

Professional memberships

  1. 2024 - present
    MemberEuropean Hematology Association
  2. 2023 - present
    MemberRemote Patient Monitoring Committee
  3. 2022 - present
    MemberLymphoid Malignancies Disease Oriented Group
  4. 2021 - present
    MemberInternational Myeloma Working Group
  5. 2021 - present
    MemberMyeloma Disease Oriented Group
  6. 2021 - present
    MemberChronic Lymphocytic Leukemia Disease Oriented Group
  7. 2021 - present
    MemberWaldenström’s Macroglobulinemia Disease Oriented Group
  8. 2019 - present
    MemberAmerican Society for Transplantation and Cellular Therapy
  9. 2019 - present
    MemberInternational Myeloma Society
  10. 2018 - present
    MemberFlorida Society of Clinical Oncology
  11. 2018 - present
    MemberDuval County Medical Society
  12. 2016 - present
    MemberAmerican Society of Hematology
  13. 2016 - present
    MemberAmerican Society of Clinical Oncology
  14. 2015 - present
    MemberAmerican College of Physicians

Publications